New Ventures Portfolio Companies

CTTC owns equity in a diverse group of companies that span a range of technologies including computerized surgical navigation, natural products for insect control, clinical information management systems, clinical diagnostics, drug discovery, radiation therapy, and healthcare services - all of which are powered by Vanderbilt technologies. The Center’s active portfolio currently includes, (non-exhaustive list):


Solutions for high-acuity care


Pneumatic valves for energy  reduction

American Sentinel University

Distance learning


Medical diagnostics

Apogee Informatics

Healthcare data consultant


Laser vapor deposition for OLED  manufacturing


Clinical IT solutions


Medical devices infused with  bionanotechnology

Cardiovascular Care Affiliates

Healthcare services

Cumberland Emerging Technologies

Life sciences business incubation

Diatech Oncology

Personalize cancer therapy

*Disciplina Advisors

Investment management


Colorectal cancer screening tool


Semiconductor materials

Immunonet Biosciences

Human genetics diagnostics

Informatics Corporation of America

Clinical IT systems

International FemtoScience, Inc.

Research & development for advanced technology


Mobile ECG solution


CQI software and services           


Crew training for healthcare

*LVR Technology

Low Vision Readers


Assay services and products

Molecular Sensing

Illuminating biological interactions


Drug delivery system


Renal disease diagnostics and therapeutics


Medical image analysis and computer assisted solutions

Pathfinder Therapeutics

Image-guided surgical navigation for soft tissue

TyraTech (TYR.L)

Natural insect control products

Universal Robotics

Robotics solutions


Drug Discovery Tools


Drug development for infectious disease




*companies formed in the last two years  

Featured Video

Vanderbilt Patent Activity

View Vanderbilt University Patents

CTTC on Twitter